Article By:
Avisol Capital Partners
Monday, August 15, 2022 11:32 AM EDT
180 Life Sciences is an under the radar stock worthy of a closer look. We sat down with CEO Dr. James Woody to dig deeper into ATNF to learn if the stock merits being added to your portfolio.